McDonald’s Q3 Preview: Don’t Worry About E. Coli, It’s An Automation Play

Summary:

  • McDonald’s Corporation is leveraging automation to drive foot traffic and reduce labor costs, positioning itself well despite wage pressures and health concerns.
  • The ‘Fight for $15’ movement poses a threat, but McDonald’s automation efforts can mitigate potential labor cost increases.
  • Despite an E. Coli outbreak, McDonald’s earnings estimates remain favorable, with automation expected to boost EPS growth.
  • McDonald’s real estate and royalty business model provides stable cash flow, making the current valuation reasonable and offering potential upside.
  • Heading into earnings, shares are a strong buy.

Mc Donalds French Fries

junce

Co-Authored By Noah Cox and Brock Heilig.

Investment Thesis

While McDonald’s Corporation (NYSE:MCD) shares are selling off today on the news of an E. Coli outbreak at stores across the US, shares overall have staged


Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Noah Cox (main account author) is the managing partner of Noah’s Arc Capital Management. His views in this article are not necessarily reflective of the firms. Nothing contained in this note is intended as investment advice. It is solely for informational purposes. Invest at your own risk.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Leave a Reply

Your email address will not be published. Required fields are marked *